M. Oflas Et Al. , "The Contribution of 18F-FES PET/CT to Therapy Management in Estrogen Receptor Positive Breast Cancer," 34. Ulusal Nükleer Tıp Kongresi , Antalya, Turkey, pp.51, 2022
Oflas, M. Et Al. 2022. The Contribution of 18F-FES PET/CT to Therapy Management in Estrogen Receptor Positive Breast Cancer. 34. Ulusal Nükleer Tıp Kongresi , (Antalya, Turkey), 51.
Oflas, M., Has Şimşek, D., Işık, E. G., Cabıoğlu, N., İbiş, K., Aydıner, A., ... Mudun, A.(2022). The Contribution of 18F-FES PET/CT to Therapy Management in Estrogen Receptor Positive Breast Cancer . 34. Ulusal Nükleer Tıp Kongresi (pp.51). Antalya, Turkey
Oflas, Melis Et Al. "The Contribution of 18F-FES PET/CT to Therapy Management in Estrogen Receptor Positive Breast Cancer," 34. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 2022
Oflas, Melis Et Al. "The Contribution of 18F-FES PET/CT to Therapy Management in Estrogen Receptor Positive Breast Cancer." 34. Ulusal Nükleer Tıp Kongresi , Antalya, Turkey, pp.51, 2022
Oflas, M. Et Al. (2022) . "The Contribution of 18F-FES PET/CT to Therapy Management in Estrogen Receptor Positive Breast Cancer." 34. Ulusal Nükleer Tıp Kongresi , Antalya, Turkey, p.51.
@conferencepaper{conferencepaper, author={Melis OFLAS Et Al. }, title={The Contribution of 18F-FES PET/CT to Therapy Management in Estrogen Receptor Positive Breast Cancer}, congress name={34. Ulusal Nükleer Tıp Kongresi}, city={Antalya}, country={Turkey}, year={2022}, pages={51} }